Current Value of Holding

$3.44B

Shares

18.1M

% of Portfolio

2.06%

Average Buy Price

$191

Avg closing price
Price range

2 PRIMECAP Management AstraZeneca PLC Trades

PRIMECAP Management acquired 18.1M AstraZeneca PLC shares worth $3.44B. That's 2.06% of their equity portfolio (9th largest holding). The investor owns 1.17% of the outstanding AstraZeneca PLC stock. PRIMECAP Management started to build up the position in AstraZeneca PLC in Q1 2026. Since then they sold 119k shares. The investor's estimated purchase price is $3.46B, resulting in a loss of 0.5%.

Avg closing price
Price range
Sold 0.7% shares (-119k shares) Q2 2026
Avg closing price -
Price range - - -
New holding (+18.2M shares) Q1 2026
Avg closing price $190.94
Price range $175.00 - $209.48

News about AstraZeneca PLC and PRIMECAP Management

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!